Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.122.011990
Abstract: Background: The benefit of dual antiplatelet therapy (DAPT) for reducing ischemic events is greatest in the early period of acute coronary syndrome, and recent randomized controlled trials have investigated the unguided de-escalation strategy of changing… read more here.
Keywords: coronary syndrome; escalation; acute coronary; guided selection ... See more keywords
Unguided De-Escalation Strategy From Potent P2Y12 Inhibitors in Patients Presented With ACS: When, Whom and How?
Sign Up to like & getrecommendations! Published in 2022 at "Korean Circulation Journal"
DOI: 10.4070/kcj.2022.0022
Abstract: https://e-kcj.org In patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is an essential strategy of their management. According to the current guidelines, it is generally recommended to… read more here.
Keywords: unguided escalation; strategy; escalation strategy; potent p2y12 ... See more keywords